Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.45 |
| ▸ | FABP7 | O15540 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 2/20 | 0.39 |
| ▸ | MDM4 | O15151 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27704397 | 1.00 | KMT2A (0.51) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL27704394 | 1.00 | KMT2A (0.51) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL30749159 | 0.92 | KMT2A (0.55) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL20586907 | 0.88 | KMT2A (0.52) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL1808220 | 0.88 | KMT2A (0.53) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL1001837 | 0.87 | KMT2A (0.46) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL97175 | 0.87 | KMT2A (0.46) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL27724921 | 0.86 | KMT2A (0.50) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL27724920 | 0.86 | KMT2A (0.50) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL30492079 | 0.86 | KMT2A (0.48) | KMT2AFABP5FABP7CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118256591-A | Cyclic peptide compound having high membrane permeability and library comprising same | 中外制药株式会社 | 2024-06-28 | — | — | CN | disclosed |
| CN-110869544-B | Cyclic peptide compound having high membrane permeability and library comprising same | 中外制药株式会社 | 2024-03-08 | — | — | CN | disclosed |
| CN-111148752-B | Peptide derivatives and pharmaceutical compositions containing the same | 国立大学法人德岛大学 | 2024-01-16 | — | — | CN | disclosed |
| CN-111432844-B | PSMA-targeting amanitine conjugates | 海德堡医药研究有限责任公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-110475785-B | Peptide compound, method for producing same, composition for screening, and method for selecting peptide compound | 富士胶片株式会社 | 2023-06-13 | — | — | CN | disclosed |
| CN-112010961-B | Solid-liquid synthesis method of somalupeptide | 深圳市健元医药科技有限公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-108779146-B | Peptide derivatives and uses thereof | 东丽株式会社 | 2022-03-18 | — | — | CN | disclosed |
| CN-111148752-A | Peptide derivatives and pharmaceutical compositions containing the same | 国立大学法人德岛大学 | 2020-05-12 | — | — | CN | disclosed |
| CN-110869544-A | Cyclic peptide compound having high membrane permeability and library containing same | 中外制药株式会社 | 2020-03-06 | — | — | CN | disclosed |
| CN-101189253-A | Antiinfective lipopeptides | CUBIST PHARM INC (US) | 2008-05-28 | — | — | CN | disclosed |
| CN-100352836-C | Novel depsipeptides and process for preparing same | CUBIST PHARM INC (US) | 2007-12-05 | — | — | CN | disclosed |
| CN-1551887-A | Novel depsipeptides and process for preparing same | ������ҩ������˾ | 2004-12-01 | — | — | CN | disclosed |